Outpatient rehab for lung cancer patients on immunotherapy
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether a structured outpatient exercise program can help people with non-small cell lung cancer who are already receiving immunotherapy. It is designed for those whose cancer is stable or responding after initial treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with advanced (stage IV) non-small cell lung cancer that has returned or spread.
- Your cancer has not been treated before and you are about to start or have completed 4 cycles of chemotherapy plus immunotherapy, and your disease is stable or improving.
- You are in good general health (able to carry out daily activities without help).
- You do not have uncontrolled medical conditions that would make exercise unsafe, such as severe heart failure, unstable chest pain, or recent heart attack or surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a combination of immunotherapy and targeted radiation for people with advanced lung cancer that has no targetable gene changes. The goal is to see if adjusting radiation based on how well the tumor responds can improve outcomes.
This study tests whether a supervised exercise program can help people with advanced lung cancer feel better and stay stronger during their cancer treatment. It is for patients who are in the early phases of palliative therapy (first or second treatment) and can safely participate in exercise.
This study tests a pulmonary rehabilitation program—special exercises and breathing training—to help people with advanced lung cancer feel less short of breath and improve their daily function and quality of life.
This trial tests whether a supervised exercise program can help improve immune activity and treatment outcomes for people with non-small cell lung cancer who are already on immunotherapy. It is designed for people who are not currently very active.
This study tests if a respiratory (breathing) rehabilitation program can improve quality of life for people with advanced non-small cell lung cancer who are on maintenance treatment after initial chemotherapy and immunotherapy.
This trial studies if a rehabilitation program can help patients with advanced non-small cell lung cancer that has been stable for at least 6 months. It aims to improve physical activity and reduce symptoms.
Hear when a new NSCLC Stage IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.